native med semaglutide PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: GobyMeds - Compounded Semaglutide |
Description
Ongoing trials and real-world data are critical to understanding these potential risks better
For context: the Wegovy injection's pivotal STEP-1 trial showed roughly 14.9% mean weight loss at 68 weeks in adults with obesity, with 86% of participants reaching at least 5% weight loss
Serious Risks to Watch For Pancreatitis (severe abdominal pain) Thyroid tumors Hypoglycemia Gallstones or acute cholecystitis If you think youre experiencing any of these issues, speak with a healthcare provider immediately
Ozempic is approved for people 18 years of age and over
